PL411078A1 - Complex silver compound, method for producing a complex compound and application of a complex compound - Google Patents
Complex silver compound, method for producing a complex compound and application of a complex compoundInfo
- Publication number
- PL411078A1 PL411078A1 PL411078A PL41107815A PL411078A1 PL 411078 A1 PL411078 A1 PL 411078A1 PL 411078 A PL411078 A PL 411078A PL 41107815 A PL41107815 A PL 41107815A PL 411078 A1 PL411078 A1 PL 411078A1
- Authority
- PL
- Poland
- Prior art keywords
- compound
- complex
- silver
- metronidazole
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Wynalazek dotyczy związku kompleksowego srebra i metronidazolu, sposobu wytwarzania tego związku, oraz zastosowania związku do wytwarzania preparatu do hamowania rozwoju mikroorganizmów chorobotwórczych, w profilaktyce lub leczeniu zwierzęcia lub człowieka. W sposobie wytwarzania związku kompleksowego srebra i metronidazolu, stosuje się jako reagenty metronidazol i związek srebra(I), który to związek srebra(I) jest co najmniej częściowo rozpuszczalny w środowisku reakcyjnym. Reagenty zestawia się w środowisku reakcyjnym zawierającym rozpuszczalnik hydroksylowy w temperaturze 5 - 90°C, i prowadzi się reakcję przez 1 - 180 minut utrzymując temperaturę 5 - 90°C ewentualnie pobudzając mechanicznie środowisko reakcyjne, a następnie wydziela się związek kompleksowy srebra i metronidazolu.The invention relates to a complex compound of silver and metronidazole, a method for preparing this compound, and the use of a compound for the preparation of a preparation for inhibiting the development of pathogenic microorganisms, in the prevention or treatment of an animal or human. In the process for producing the silver compound and metronidazole, metronidazole and a silver (I) compound are used as reactants, which silver (I) compound is at least partially soluble in the reaction medium. The reactants are combined in a reaction medium containing a hydroxyl solvent at a temperature of 5 - 90 ° C, and the reaction is carried out for 1 - 180 minutes, maintaining the temperature at 5 - 90 ° C, optionally mechanically stimulating the reaction environment, and then the silver and metronidazole complex compound is isolated.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
PCT/EP2016/051710 WO2016120332A1 (en) | 2015-01-27 | 2016-01-27 | Silver complex compound, the method of preparation of the complex compound and the use of the complex compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
Publications (1)
Publication Number | Publication Date |
---|---|
PL411078A1 true PL411078A1 (en) | 2016-08-01 |
Family
ID=55236377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL411078A1 (en) |
WO (1) | WO2016120332A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607159D0 (en) * | 1986-03-22 | 1986-04-30 | Smith & Nephew Ass | Pharmaceutical composition |
WO1997002038A1 (en) | 1995-06-30 | 1997-01-23 | Capelli Christopher C | Silver-based pharmaceutical compositions |
US6093414A (en) * | 1997-08-11 | 2000-07-25 | Christopher C. Capelli | Silver-based antimicrobial compositions |
WO1998006260A1 (en) * | 1996-08-16 | 1998-02-19 | Capelli Christopher C | Silver-based antimicrobial compositions |
CN102688258A (en) * | 2012-06-16 | 2012-09-26 | 李泽红 | Medicine for external use for treating psoriasis, leucoderma, fungus infection and bromhidrosis |
PL404583A1 (en) * | 2013-07-08 | 2015-01-19 | Uniwersytet Medyczny w Łodzi | A silver complex compound, a method for producing the compound, and the use of the compound |
-
2015
- 2015-01-27 PL PL411078A patent/PL411078A1/en unknown
-
2016
- 2016-01-27 WO PCT/EP2016/051710 patent/WO2016120332A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016120332A1 (en) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
MX2018015853A (en) | Multispecific antibodies against cd40 and cd137. | |
MX2020000387A (en) | General and direct method for preparing oligonucleotide-functiona lized metal-organic framework nanoparticles. | |
MX2019009861A (en) | Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof. | |
MX2022014914A (en) | Glycan-interacting compounds and methods of use. | |
MX2020001757A (en) | Compounds, salts thereof and methods for treatment of diseases. | |
MX2018015892A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2018014849A (en) | Adenosine derivatives for use in the treatment of cancer. | |
MX2017016325A (en) | Brk inhibitory compound. | |
PH12015502414A1 (en) | Enhancer of zeste homolog 2 inhibitors | |
PL412787A1 (en) | Macrophage-based aimed system for delivery of ferritin related compounds | |
EA201891526A3 (en) | INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1 | |
CY1124387T1 (en) | METHOD FOR PRODUCING A NEW NITROGEN-CONTAINING CHEMICAL COMPOUND OR SALT THEREOF, AND PRODUCING AN INTERMEDIATE THEREOF | |
MX2020006237A (en) | Compounds for treatment of diseases related to dux4 expression. | |
MX2019008808A (en) | Pyrimidine compound and pharmaceutical use thereof. | |
PH12021550382A1 (en) | Tetrahydropyridopyrimidine derivatives as ahr modulators | |
PH12018502337A1 (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
PH12018502314A1 (en) | Enhancer of zeste homolog 2 inhibitors | |
CR20210294A (en) | Heteroaromatic compounds as vanin inhibitors | |
JOP20210034A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
EA201790604A1 (en) | Inhibitors of histonedehylase | |
WO2019036417A3 (en) | Inhibition of ngly1 for the treatment of cancer | |
EA201992196A1 (en) | METHOD FOR SYNTHESIS OF ZEOLITE CRYSTALS WITH AN EXTENDING AGENT | |
UA117524C2 (en) | Plant stimulators, use thereof and method of plant stimulation | |
PL411078A1 (en) | Complex silver compound, method for producing a complex compound and application of a complex compound |